As shown in Figure 7A, a significant decrease (p = 0.016) of STAT5B expression when the MPN cell lines (UKE-1 and SET-2) were treated with PCI34051 in the presence of JAK2-MSC. The gene discussed is JAK2; the disease is myeloproliferative neoplasm.